Answers are grounded in this paper and cite their sources.
Investigates how quercetin affects the structure and thermal properties of zinc-modified hydroxyapatites, highlighting significant changes in properties.
In this study, hydroxyapatite (HAp) samples, co-doped with 0.44 at.% of zinc and different amount of quercetin (Zn/Que-HAp), were synthesised using a wet-chemical method and calcined at 900°C. XRD shows HAp as the primary phase with minor β-TCP. Compared to the Zn-doped sample without quercetin (Q1), quercetin co-doping induces clear structural changes (shifts of lattice parameters a from −0.0017 to +0.0006 nm and c from −0.0026 to −0.0005 nm), accompanied by changes in crystallinity (from −3.6% to +2.5%) and crystallite size (from −3.5 to +0.6 nm), evidencing a distinct co-doping effect. DTA/TGA reveal reduced total mass loss for the Que-containing compositions relative to the Zn-doped sample, indicating enhanced thermal stability of the co-doped lattice. SEM reveals granular morphologies with interconnected porosity, while EDX yields (Ca+Zn)/P ratios greater than 1.67, consistent with Ca-sufficient apatite and modified defect chemistry. DFT calculations resolve the site-specific effects of Zn substitution and predict a preference for perturbation at Ca2 sites. The electronic density of states retains a wide-gap, insulating character, with localised states sensitive to the dopant configuration. By correlating experiment and theory, we demonstrate that the organic-inorganic co-dopant pair offers an effective means to tune lattice metrics, phase balance, and thermal response without compromising the intrinsic insulating nature of HAp.
No takes yet. Share an insight, caveat, or question.
Keser et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: